Corrigendum to "ZY0511, a novel, potent and selective LSD1 inhibitor, exhibits anticancer activity against solid tumors via the DDIT4/mTOR pathway" [Cancer Lett. 454 (2019) 179-190].
| Authors | Yan Li, Lei Tao, Zeping Zuo, Yang Zhou, Xinying Qian, Yiyun Lin, Hui Jie, Chunqi Liu, Zhuoling Li, Huaqin Zhang, Hu Zhang, Xiaobo Cen, Shengyong Yang, Yinglan Zhao |
| Journal | Cancer letters
(Cancer Lett)
Vol. 461
Pg. 153-154
(Oct 01 2019)
ISSN: 1872-7980 [Electronic] Ireland |
| PMID | 31103248
(Publication Type: Published Erratum)
|
|
Join CureHunter, for free Research Interface BASIC access!
Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease.
Find out why thousands of doctors, pharma researchers and patient activists
around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!
|
